

UPCOMING EVENTS

RESEARCH FUNDING OPPORTUNITIES
ACT funding
Nursing and Midwifery Scholarships
​​
Closing date: Variable
The ACT Government and university scholarships and professional development opportunities for nursing and midwifery professionals.
NSW funding
Cancer Quality Improvement Collaboration Grant for Aboriginal Medical Services
​
Grant Amount: $130,000
Closing Date: Ongoing
The objective of this grant is to enable collaborative efforts between Aboriginal Medical Services and Primary Health Networks to contribute to a cancer system that is responsive to the needs of Aboriginal people.
This grant will enable workshop hosting, attendance, travel, accommodation and the development of cancer quality improvement initiatives.
This program is funded and administered by Cancer Institute NSW.
National funding (Australia)
Cancer Australia
​
Grant Amount: up to $700,000
Closing Date: 3 February 2026
The 2025 Partnerships for culturally safe cancer care grant program supports innovative, community-informed approaches to accelerate the delivery of culturally safe, accessible, and responsive cancer care for Aboriginal and Torres Strait Islander people.
MRFF – Clinical Trials Activity Initiative – 2025 International Clinical Trial Collaborations Grant Opportunity
​
Grant Amount: up to $3 million
Closing Date: 4 February 2026 (minimum data due 28 January 2026)
The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:
-
Promote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.
-
Provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in ‘usual care’ settings, which will support a decision on whether to deliver the intervention in an Australian setting.
MRFF – Australian Brain Cancer Mission – 2025 Brain Cancer Research Grant Opportunity
Grant Amount: up to $2,000,000
Closing Date: 4 February 2026
The Medical Research Future Fund (MRFF) Australian Brain Cancer Mission aims to support transformative improvement to the quality and length of life of people with brain cancer, with the longer-term aim of defeating brain cancer.
Cancer Australia
​
Grant Amount: up to $250,000
Closing Date: 6 February 2026
The Networking for Cancer Equity grant program supports innovative, collaborative models that strengthen networks and partnerships to improve access to comprehensive cancer care for people living in outer-metropolitan, regional, rural, and remote areas.
MRFF - EPCDRI - 2025 Childhood Mental Health Research Grant Opportunity
​
Grant Amount: up to $5,000,000
Closing Date: 25 March 2026
The Medical Research Future Fund (MRFF) Emerging Priorities and Consumer-Driven Research initiative aims to enable or support research that improves patient care and translation of new discoveries, and encourage collaboration between consumers and researchers. Funding from this Initiative will support the development of new diagnoses, treatments and cures, and the translation of new discoveries into clinical practice.
MRFF 2022 Frontier Health and Medical Research Grant Opportunity
​
Grant Amount: up to $25,000,000
Closing Date: 31 March 2026
This grant opportunity offers funding to support medical research and medical innovation programs of research that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re-purpose existing health technologies in a novel way.
MRFF – CTA Initiative – 2025 Clinical Trials Activity Grant Opportunity
​
Grant Amount: up to $25,000,000
Closing Date: 1 April 2026
The Medical Research Future Fund (MRFF) Clinical Trials Activity Initiative aims to:
-
improve the evidence base supporting clinical care
-
help patients access trials relevant to their health circumstances
-
enable researchers to bring international trials to Australian patients.






